Summit Investment Advisors »

Elevation Oncology shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Elevation Oncology

Tip: Access up to 7 years of quarterly data

All positions including Elevation Oncology held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elevation Oncology by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.9k 5.1k 0.56
2024-09-30 $3.1k 5.1k 0.60
2024-06-30 $14k 5.1k 2.70

More positions owned by Summit Investment Advisors

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Ishares Tr Etf (IVV)
Broadcom (AVGO)
Vanguard Europe Pacific ETF (VEA)
Vanguard S&p 500 Etf idx (VOO)
Alphabet Inc Class C cs (GOOG)
Spdr Ser Tr Etf (ONEV)
iShares Lehman Aggregate Bond (AGG)
Tesla Motors (TSLA)
Facebook Inc cl a (META)
iShares S&P 500 Growth Index (IVW)
Alphabet Inc Class A cs (GOOGL)

View all positions for Summit Investment Advisors

Top funds holding Elevation Oncology

Frazier Life Sciences Management
Tang Capital Management
Farallon Capital Management
BlackRock
BVF
Aisling Capital Management
Vanguard Group
Goldman Sachs Group
Renaissance Technologies
Geode Capital Management
State Street Corporation
Sphera Funds Management
OrbiMed Advisors
Millennium Management
Ikarian Capital

View all funds holding Elevation Oncology